25-hydroxyvitamin D3(25-OH-D3) was studied in primary cultures of pulmonary alveolar macrophages (PAM) from seven patients with sarcoidosis and two patients with idiopathic pulmonary fibrosis. Production of a [3H]1,25-dihy-
INTRODUCTION
Disordered calcium metabolism is a frequently encountered clinical problem in sarcoidosis. The reported incidence of hypercalcemia in the disease may range as high as 20% (1) , while the incidence of hyReceived for publication 8 June 1983 and in revised form 18 August 1983. percalciuria, a major source of morbidity in sarcoidosis, may be twice as great (2) . The proposed etiology for this phenomenon is extrarenal overproduction of the active metabolite of vitamin D, 1,25-dihydroxyvitamin D (1,25-[OH]2-D)' (3, 4) . A possible cellular source for 1,25-(OH)2-D or a related sterol is the macrophage, a ubiquitous constituent of the noncaseating granulomata of sarcoidosis. In this report, we demonstrate production in vitro of a 1,25-dihydroxyvitamin D3 (1,25-(OH)2-D3)-like metabolite of [3H]25-hydroxyvitamin D3 (25-OH-D3) by primary cultures of pulmonary alveolar macrophages (PAM) harvested from patients with active sarcoidosis.
METHODS
Patients. Bronchoalveolar lavage was performed in seven patients with biopsy-proven sarcoidosis and two patients with idiopathic pulmonary fibrosis. Five patients with sarcoidosis had roentgenographic evidence of diffuse infiltrative pulmonary disease with or without hilar lymphadenopathy ( Eagle's NMedium supplemented with 10% fetal bovine serum, 4 mM glutamine, 10 ug/ml insulin, 50 U/ml penicillin, and 50 ,g/ml streptomycin (all from Gibco Laboratories, Grand Island, NY) and maintained in an atmosphere of 5% C02:95% air at 37°C. Nonadherent cells were decanted in the culture medium 12-24 h after plating the cells. Thereafter, the culture medium vas changed twice weekly. Nonviable macrophages (ascertained by failure to exclude trypan blue) were harvested from the culture medium and retained for use as controls in subsequent experiments.
[311]25-OH-D3 metabolism. After 7-12 d in primary cullture, the homogeneity of the cell populations was confirmed by histochemical staining for nonspecific esterase activity by using a-napthyl acetate as substrate (7) (8) . Cultuires were incubated for 3 h at 370C in [3H]25-OH1-D3-containing medium. At the conclusion of 3-h incubation period, the medium was aspirated and the cell monolayer harvested by gentle scraping. The lipid was extracted from the cells and the incubation medium in methanol-methylene chloride, and the resultant extracts were chromatographed oin silica Sep-Pak cartridges.
The builk of the radioactivity in the form of unmetabolized
[3H]25-OH-D3 was eluted in 15 ml of 25/c ethylacetate in nhexane. More polar material was eluted in 15 ml of 100% ethylacetate. The latter fraction was evaporated under nitrogen and resolubilized for straight-phase high performance liquid chromatography (HPLC) over a 3.9 mm X 30 cm AuPorasil column (WVaters Associates) in a mobile phase of 92% n-hexane:4% methanol:4% isopropanol eluting at 2.0 ml/min. Each sample was co-chromatographed with crystaline standards of 25-OH-D3, 24(R),25-(OH)2-D3, 25,26-(O1)2-D13, and I,25-(OH)2-D3; and the radioactivity coeluting with unlabeled standards was determined. Co-chromatography of labeled product vith 1,25-(OH)2-D3 was confirmed in each case by straight-phase HIPLC in a different solvent system of 98% methylene chloride:2% methanol (see (Table I) In an attempt to functionally characterize the tritiated metabolite, the PAM-derived material was employed as radiolabeled ligand for binding to the high-affinity intracellular binding protein (receptor) for 1,25-(OH)2-D3 (Fig. 2) 
